Search for: "Astellas Pharma US, Inc." Results 1 - 20 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2023, 7:07 pm
Reporting on recent investigation of Bain & Co.'s Shanghai offices, the rad on the Beijing offices of Mintz Group, cyber reviews of Micron Technology, Inc., and the detention of a Japanese employee of Astellas Pharma, Inc., suggests a broader purpose.Business executives who have consulted with Chinese authorities said the government aims to limit the information collected by foreign companies such as auditors, management consultants, and law firms that… [read post]
22 Oct 2021, 2:10 pm by Tom Lamb
As stated in our initial article about serious Padcev skin reactions last month, we are investigating cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients using Padcev as possible drug injury lawsuits to be filed against Astellas Pharma US, Inc., the manufacturer of Padcev. [read post]
21 Sep 2021, 1:25 pm by Tom Lamb
Our law firm is investigating cases for patients who have suffered the Padcev skin side effects Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) as possible drug injury lawsuits to be filed against Astellas Pharma US, Inc., the manufacturer of Padcev. [read post]
28 Apr 2020, 11:46 pm by Brian Cordery (Bristows)
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
31 May 2018, 4:26 pm by Kevin LaCroix
  Background Astellas Pharma U.S. is a pharmaceutical company and the U.S-based subsidiary of Astellas Pharma, Inc. [read post]
12 Jul 2016, 7:22 am by Law Offices of Jeffrey S. Glassman
Both defendants in the case have since been purchased by other firms – OSI by Japanese company Astellas Pharma and Genetech by Swiss firm Hoffman-La Roche AG. [read post]
7 Feb 2016, 9:59 pm by Patent Docs
Apotex Inc. et al. 1:15-cv-00857; filed September 22, 2015 in the District Court of Delaware • Plaintiffs: Astellas Pharma Inc.; Astellas US LLC; Astellas Pharma US, Inc. [read post]
3 Sep 2014, 4:01 pm
This is the question which the IPKat posed last Friday, on learning that Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, a reference to the Court of Justice of the European Union (CJEU) of some questions relating to the so-called Bolar exemption, which spares some sorts of use of someone else's patent for experimental purposes from being a patent infringement. [read post]
29 Aug 2014, 7:30 am
Readers may still be looking forward to a ruling from the Court of Justice of the European Union (CJEU) in Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, which was excitedly publicised by this Kat here and here on account of its potential for clarifying the scope of Bolar exemptions from patent infringement in favour of experimental use. [read post]
24 Jun 2014, 6:58 am by Duets Guest Blogger
However, I have never resorted to choosing random letters out of a hat…which is the only explanation I can come up with for why Astellas Pharma US, Inc. chose this name. [read post]
20 Apr 2014, 8:26 pm by Ben Vernia
Astellas Pharma US Inc., located in Northbrook, Ill., manufactures and sells pharmaceutical drugs, including Mycamine [read post]
5 Feb 2014, 2:16 am
Case C-661/13 Astellas Pharma Inc, a reference for a preliminary ruling to the Court of Justice of the European Union (CJEU) from the Oberlandesgericht Düsseldorf, Germany, came into the IPKat's line of vision in mid-January thanks to katfriend Paul England (see earlier Katpost here). [read post]
15 Jan 2014, 7:38 am
Pharmaceutical Works and Japanese company Astellas Pharma Inc; if you must know, the patent is for novel quinuclidine derivatives and pharmaceutical preparations. [read post]
7 Sep 2012, 1:38 pm
Daniels, 42, of North Naples, a pharmaceutical representative, and his employer, Astellas Pharma U.S. [read post]
3 Jun 2012, 8:34 pm by Patent Docs
Hospira Inc. 1:12-cv-00652; filed May 23, 2012 in the District Court of Delaware • Plaintiffs: Astellas US LLC; Astellas Pharma US, Inc.; Item Development AB • Defendant: Hospira Inc. [read post]